top of page


Feature Paper: Suppressed Ketosis, Hypoketonaemia, Raises GKI and Liver Markers in Lean Women - Cover of the MDPI Livers, Volume 5, Issue 3 (September 2025)
Cover Story : The KetoSAge human trial examined ten lean, healthy, pre-menopausal women who were habitually in ketosis (~3.9 years). Participants suppressed ketosis-inducing hypoketonaemia for 21 days via a higher carbohydrate intake, aligned with standard healthy eating guidelines, before returning to euketonaemia. Hypoketonaemia resulted in significant increases in ALT (~1.9-fold), GGT (1.3-fold), ALT/AST (1.30-fold), GKI (22.23-fold), and HOMA-IR (2.13-fold). These metabol
5 days ago1 min read


Welcome to Forever Young Group!
As a group of scientists, it became apparent that our research was unified by some common themes surrounding metabolic health, longevity, ageing, and age-related diseases. Given our range of scientific skills, experience, and technical expertise, we decided to work together to tackle some big questions surrounding diseases like diabetes, cancer, and liver disease. You can find out more about our individual research projects by checking out our About Us page. We are looking
Mar 6, 20231 min read
bottom of page